nefopam

Trade name: Acupan

Small moleculeexperimental

Nefopam, sold under the brand name Acupan among others, is a centrally acting, non-opioid painkilling medication, with central stimulant and sympathomimetic properties that is primarily used to treat moderate to severe pain. — Wikipedia

Chemistry & pharmacology

Loading structure…

SMILES

CN1CCOC(c2ccccc2)c2ccccc2C1
Mol. weight
253.35 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Racemic Mixture
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • acupan
  • acupan
  • acupan
  • fenazoxine
  • nefopam
  • nefopam
  • nefopam
  • nefopam
  • nefopam
  • nefopam
  • nefopam
  • nefopam
  • (+/-)-nefopam
  • nefopam hcl
  • nefopam hcl
  • nefopam hcl
  • nefopam hydrochloride
  • nefopam hydrochloride
  • nefopam hydrochloride

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06627816N/AOct 31, 2024Cairo University
NCT06349798Phase 3Apr 30, 2024University Hospital, Tours
NCT06680609Early Phase 1 (Phase 1)Jun 1, 2023Jordan University, King Abdullah Medical City
NCT05861791N/AFeb 7, 2023Chung-Ang University
NCT05648058Phase 3Dec 20, 2022Government of Iraq
NCT05173337N/ADec 8, 2021Kangbuk Samsung Hospital
NCT05129137Phase 1Nov 15, 2021Accutest Research Laboratories (I) Pvt. Ltd., Unither Pharmaceuticals
NCT05071352Phase 3Oct 31, 2021Cairo University
NCT04685577Phase 2Jan 31, 2021University of Alberta
NCT04622813Phase 3Dec 31, 2020American University of Beirut
NCT04870541Phase 4Dec 1, 2020Saint-Joseph University
NCT04622735Phase 3Nov 30, 2020EXCELYA, Unither Pharmaceuticals, University of Birmingham
NCT04576078Phase 2Oct 31, 2020Hopital de la Croix Rousse, University of Lyon
NCT04241640Phase 4Jul 31, 2020Mahidol University
NCT04450355N/AJul 1, 2020Pharmbio Korea, Seoul National University
NCT03955705N/AMay 31, 2019Mahidol University
NCT03462836N/AApr 1, 2018Yonsei University
NCT02441673Phase 2Oct 1, 2017Lagos State Health Service Commission
NCT04110665Phase 4Sep 1, 2017Centre Hospitalier Universitaire de Nīmes
NCT03036306Phase 1Jan 1, 2017ScarX Corp
Showing 20 of 45 trials
Page 1 / 3

Organizations

Research & Development (36)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Seoul National UniversityAcademic/Hospital7732012
Yonsei UniversityAcademic/Hospital7722012
Pharmbio KoreaFor profit3032012
University Clermont AuvergneAcademic/Hospital3332008
Cairo UniversityAcademic/Hospital2222021
Centre Hospitalier Universitaire de NīmesAcademic/Hospital2222011
Mahidol UniversityAcademic/Hospital2222019
Unither PharmaceuticalsFor profit2222020
Accutest Research Laboratories (I) Pvt. Ltd.For profit1012021
American University of BeirutAcademic/Hospital1112020
BiocodexFor profit1012004
Biokinetic Europe LtdFor profit1012015
Catholic University of KoreaAcademic/Hospital1112011
Chung-Ang UniversityAcademic/Hospital1112023
EXCELYAFor profit1012020
GalenFor profit1112015
Government of IraqGovernment1112022
Hallym UniversityAcademic/Hospital1112015
Hopital de la Croix RousseAcademic/Hospital1012020
Jordan UniversityAcademic/Hospital1012023
36 organizations
Page 1 / 2